# Trade Mark Journal No.2026/001 2 January 2026

## WO0000001892741 (1)

Office of origin: United States of America

Date of International Registration:16 November 2025
Date of designation in the UK: 16 November 2025

International priority date claimed: 14 November 2025 (United States of America) (99496466)

Class 1
  Excipients for use in the manufacture of pharmaceutical preparations.

SPI Pharma, Inc.

Representative: William C Wright Epstein Drangel LLP, 60 East 42nd Street, Suite 1250, New York NY 10165, UNITED STATES OF AMERICA